# A salt-water shot shows whether platelet-rich plasma added relief *Why Saline Matters — Regenerative Medicine Tempe* > Does regenerative medicine work? This regenerative medicine Tempe page explains salt-water shots, platelet-rich plasma and what a fair test can show. Soreness can ease today and rise again tomorrow. That can happen even when your care hasn't changed. Sleep, activity, and a recent flare can all affect the joint. A new treatment can change what you'll notice too. Saline means salt water, and researchers may place it in the joint with a shot. One group gets platelet-rich plasma, shortened to PRP, as the blood treatment being tested. Another group gets the salt-water shot. Both groups go through a similar visit, so the main planned difference is what was in the shot. Now comes the useful part. If the PRP group does better, the blood treatment may deserve credit. If both groups improve about the same, that study didn't show added relief from PRP. If it were my bill, I’d want to know which result the clinic meant. ## The two groups show what the PRP blood shot added People in both groups may rest more after the visit. They may move more carefully or expect to improve. The soreness might also settle on its own. Because both groups share those things, researchers compare their relief instead of giving PRP credit for every change. The initials PRP mean platelet-rich plasma, a treatment made after blood is drawn. The blood is spun so more platelets sit in a smaller amount of liquid. A provider puts that prepared liquid in the aching joint with a shot. Some papers call this a biologic therapy, which here simply means treatment made from the person's own blood. Studies don't all give the same answer. Some found that PRP didn't beat the salt-water shot for soreness. Others found more relief for some groups. QC Kinetix can discuss non-surgical PRP choices after examining your joint, but one study can't predict your result. ## Your daily change matters more than a sales claim Choose one motion that the joint limits now. Try rising from your usual chair, reaching one shelf, or crossing a familiar store. Write down the motion and how you'll feel later. Keep the check simple enough to repeat. Watch that same motion over several days. Don't judge care by one easy morning. Relief matters even when a study can't prove exactly what caused it. Still, price and risk matter more when the treatment itself might not be the reason. Here’s the honest limit. A group result can't tell you whether you'll improve. Ask what relief was measured, how long it lasted, and what happened after it wore off. You can think it over without turning possible help into a promise. ## Sources 1. A meta-analysis of 14 placebo cohorts from 13 Level-1 knee OA injection trials (1,076 patients, KL 1-4) measured what the SALINE arms did. Intra-articular normal saline produced a statistically significant VAS pain improvement at 3 months (MD 12.10) and a larger one at 6 months (MD 16.62), reaching clinically meaningful thresholds. Any uncontrolled report of 'my injection worked' has to clear this bar before it means anything about the injectate. Saltzman BM, et al. — [The Therapeutic Effect of Intra-articular Normal Saline Injections for Knee Osteoarthritis: A Meta-analysis of Evidence Level 1 Studies.](https://pubmed.ncbi.nlm.nih.gov/28027657/). *The American journal of sports medicine*, 2017. DOI: 10.1177/0363546516680607. 2. A network meta-analysis in Annals of Internal Medicine showed that placebo treatments in osteoarthritis trials are not equivalent to one another: the delivery route itself changes the response, with intra-articular placebo producing larger effects than oral placebo. This is a structural reason to distrust any comparison of an injected product against a pill, or against no treatment. Bannuru RR, et al. — [Effectiveness and Implications of Alternative Placebo Treatments: A Systematic Review and Network Meta-analysis of Osteoarthritis Trials.](https://pubmed.ncbi.nlm.nih.gov/26215539/). *Annals of internal medicine*, 2015. DOI: 10.7326/M15-0623. 3. A Mayo Clinic single-blind placebo-controlled trial used each patient as their own control: 25 patients with BILATERAL knee OA received bone marrow aspirate concentrate in one knee and saline in the other. Pain fell significantly in BOTH knees at 1 week, 3 months and 6 months - and the relief, described by the authors as dramatic, did NOT differ significantly between the BMAC knee and the saline knee. No serious adverse events occurred. Shapiro SA, et al. — [A Prospective, Single-Blind, Placebo-Controlled Trial of Bone Marrow Aspirate Concentrate for Knee Osteoarthritis.](https://pubmed.ncbi.nlm.nih.gov/27566242/). *The American journal of sports medicine*, 2017. DOI: 10.1177/0363546516662455. 4. A randomized trial of 50 completed patients (mean age 63) compared ultrasound-guided 25% dextrose prolotherapy with intra-articular normal saline for knee OA. BOTH groups improved significantly in pain, function and knee extension at every follow-up (p<0.001), and prolotherapy was neither statistically nor clinically superior to saline. Adverse events were limited to injection-site pain and bruising resolving by week 4. Teymouri A, et al. — [Comparison of the efficacy of ultrasound-guided dextrose 25% hypertonic prolotherapy and intra-articular normal saline injection on pain, functional limitation, and range of motion in patients with knee osteoarthritis; a randomized controlled trial.](https://pubmed.ncbi.nlm.nih.gov/40165187/). *BMC musculoskeletal disorders*, 2025. DOI: 10.1186/s12891-025-08580-5. 5. The RESTORE trial - a participant-, injector- and assessor-blinded RCT of 288 adults aged 50+ with symptomatic medial knee OA (Kellgren-Lawrence 2-3) - compared three weekly intra-articular PRP injections against saline placebo, with co-primary endpoints of 12-month knee pain and medial tibial cartilage volume on MRI. PRP did not beat placebo on either. It is the single best-designed test of the specific claim that PRP changes joint structure, and it was negative. Bennell KL, et al. — [Effect of Intra-articular Platelet-Rich Plasma vs Placebo Injection on Pain and Medial Tibial Cartilage Volume in Patients With Knee Osteoarthritis: The RESTORE Randomized Clinical Trial.](https://pubmed.ncbi.nlm.nih.gov/34812863/). *JAMA*, 2021. DOI: 10.1001/jama.2021.19415. 6. FORWARD, the longest disease-modifying osteoarthritis drug trial reported to date, gave intra-articular sprifermin (a recombinant FGF-18) or placebo to knee OA patients and followed 378 of them for 5 years. Sprifermin produced a significant, sustained dose-response INCREASE in total femorotibial cartilage thickness versus placebo - and WOMAC pain improved about 50% from baseline in ALL groups, including placebo. It is the cleanest demonstration in the literature that adding measurable cartilage and relieving pain are two different results, and that one does not deliver the other. Eckstein F, et al. — [Long-term structural and symptomatic effects of intra-articular sprifermin in patients with knee osteoarthritis: 5-year results from the FORWARD study.](https://pubmed.ncbi.nlm.nih.gov/33962962/). *Annals of the rheumatic diseases*, 2021. DOI: 10.1136/annrheumdis-2020-219181. ## Bring your questions to the visit At its Chandler location, QC Kinetix provides regenerative treatment options such as platelet-rich plasma, or PRP, a joint shot made after your blood is drawn and spun to gather platelets into less liquid. Tell the provider which joint is sore, how the trouble began, and what care you've tried. The clinic's full address is 1100 S. Dobson Rd., Suite 210, Chandler, AZ 85286; the shared number is (602) 837-PAIN. Book a free consultation: --- Why the joint aches, what may help, and when to have it checked. Clear help with joint soreness: urgent signs, simple steps, blood-based treatment, and Tempe clinic details. Clear facts about joint aches, care choices, and reaching a nearby clinic. This site is operated by the owners of the QC Kinetix Phoenix-area clinics, including Chandler, Scottsdale, Peoria and Banner Estrella, and those owners benefit when a reader books a consultation. © 2026 Tempe Outcome Lab. This is general education only; a qualified clinician should guide personal medical decisions.